Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at Standard Surgical Risk
Author(s) -
Katherine Vilain,
Elizabeth A. Magnuson,
Haiyan Li,
Wayne M. Clark,
Richard J. Begg,
Albert D. Sam,
W. Charles Sternbergh,
Fred A. Weaver,
William A. Gray,
Jenifer H. Voeks,
Thomas G. Brott,
David J. Cohen
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.112.661355
Subject(s) - medicine , carotid endarterectomy , carotid stenting , endarterectomy , stroke (engine) , surgery , carotid arteries , cost effectiveness , risk analysis (engineering) , mechanical engineering , engineering
The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) demonstrated similar rates of the primary composite end point between carotid artery stenting (CAS) and carotid endarterectomy (CEA), although the risk of stroke was higher with CAS, and the risk of myocardial infarction was higher with CEA. Given the large number of patients who are candidates for these procedures, an understanding of their relative cost and cost-effectiveness may have important implications for health care policy and treatment guidelines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom